Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Looking ahead to fiscal year 2026, Evercore ISI projects an EPS growth of roughly 7% to $9.10. This forecast is based on a ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

Evercore ISI analyst Liisa Bayko notes that Akero Therapeutics’ (AKRO) stock is trading up over 100% after the company released “impressive” ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...

Evercore ISI added United Parcel Service ( NYSE: UPS) to its Tactical Outperform list ahead of the parcel delivery giant's ...

The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s ...

Evercore ISI Director of Research Marc Harris said, “Artificial intelligence is already a transformative force in the U.S. economy, revolutionizing industries and driving innovation. Scaling ...

6) Credit Market Turmoil: Another possible surprise that could occur in 2025 is a widening of credit spreads, even without a recession. Growth concerns stemming from China or US policy uncertainty ...

Evercore ISI expressed on Friday that Wall Street will likely see more of what it experienced in 2024, as the investment institution stated “Fill IT up again” in 2025 indicating its positive ...

Evercore ISI raised the firm’s price target on Arista Networks (ANET) to $130 from $110 and keeps an Outperform rating on the ...